National immunisation coverage has increased for the first time in five years, for almost all vaccinations. For children born in 2017, vaccination coverage against mumps, measles and rubella (MMR) increased by 0.7% to 93.6%. National vaccination coverage for the HPV vaccination for girls, born in 2005, also increased by 7.5% to 53%. This has become apparent in the annual report on Surveillance and Developments of the National Immunisation Programme. Read more about RIVMNational Institute for Public Health and the Environment ’s annual report on vaccination coverage and the Dutch National Immunisation Programme 2019-2020.
RIVM conducts clinical studies on the safety and efficacy of vaccines. In addition, studies are underway to improve the National Immunisation Programme. This includes improving the vaccination schedule and reducing the number of injections. We advise the Dutch Government on immunology and vaccinology and carry out research to generate knowledge and data on the immune response to infectious diseases and to vaccinations offered in the framework of the government’s infectious disease control programme.